PALM BEACH GARDENS, FL--(Marketwired - January 22, 2014) - The Radiant Creations Group, Inc. ("Radiant") ("RCGP") (RCGP), developer of unique, proprietary scientific technologies and cosmetic and over-the-counter personal enhancement products and devices, is pleased to provide the market with its third quarter financials for the period ending November 30, 2013. The full 10-Q filing is available on the SEC's website:
Third quarter ending November 30, 2013 provided revenues of $65,315 and year-to-date revenues of $102,987. The quarterly revenue increased 73.4% quarter-over-quarter. Net loss for the quarter ended November 30, 2013 was $158,914 and year-to-date loss was $1,226,213.
Gary D. Alexander, CFO of Radiant stated "We are pleased to provide our financials to the investing public and to show our revenue growth. We were able to expand the revenue on sales of our first product, Revivasol - Anti-Aging and Revitalizing skin cream through our unique on-line marketing platform. Looking forward, we anticipate a rapid increase in revenue over the next months. We have worked meticulously to provide a compelling product for the cosmetics sector, to establish productive and elegant sales channels and to market Revivasol as aggressively as possible. Based on our revenue projection model, through this date, anticipated cash flow will propel the Company to release its second product -- Revivasol - Acne Gone by the middle of 2014."
About The Radiant Creations Group, Inc. (RCGP)
Radiant Creations has achieved exciting breakthroughs creating remarkable products in skin protection and hydration, anti-aging, liver health and weight balance by combining DNA technologies developed in the Western World and naturally acting traditional Chinese medicine ingredients believed never before used in western culture by any bioscience company.
Among these exciting discoveries is a new and superior mechanism of defense against skin deterioration and damage caused by sun exposure to ultraviolet (UV) light using the nucleotides, four "code molecules" extracted from DNA. This revolutionary mechanism also has great significance and value in many other cosmetic and non-cosmetic applications requiring UV protection, and is among Radiant Creations' licensed patented intellectual property. The technology will be implemented across numerous innovative product lines.
Cautionary Statement Concerning forward-Looking Statements:
This press release contains forward-looking statements that can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects" and similar references to future periods.
Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Any forward-looking statement made by us in this press release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.